title: Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel.
abstract: Charybdotoxin (ChTX) inhibits with high affinity a voltage-gated K+ channel that is present in human T lymphocytes. In this system, 125I-ChTX binds specifically and reversibly to a single class of sites which display a Kd of 8-14 pM, as measured by either equilibrium or kinetic binding protocols. The maximum density of sites, 542 sites/cell, correlates well with the density of K+ channel as determined by electrophysiological experiments. Binding of 125I-ChTX is modulated by the ionic strength of the incubation media and by Ca2+. Increasing concentrations of either K+, Na+, or Ca2+ cause inhibition of toxin binding. Inhibition of binding by Ca2+ is due, primarily, to an effect on toxin dissociation rates. Increasing the pH of the external media from 6.8 to 8.5 enhances toxin binding, due to an increase in affinity with no significant effect on the maximum density of receptor sites. Different agents that block the voltage-gated K+ channel in human T lymphocytes, inhibit toxin binding. Mitogen-stimulated T cells display 2.5-3-fold increase in toxin binding as compared with unstimulated control cells. These data, taken together, suggest that 125I-ChTX binding sites identified in this study, represent the predominant voltage-gated K+ channel present in peripheral human T lymphocytes. Therefore, 125I-ChTX is a useful probe for elucidating the physiological role of this type of K+ channel.
authors.affiliation: Department of Physiology, University of Pennsylvania, Philadelphia 19104.
authors.forename: C
authors.initials: C
authors.lastname: Deutsch
authors.forename: M
authors.initials: M
authors.lastname: Price
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: V F
authors.initials: VF
authors.lastname: King
authors.forename: M L
authors.initials: ML
authors.lastname: Garcia
mesh_terms: D001665:Binding Sites; D018999:Charybdotoxin; D006801:Humans; D006863:Hydrogen-Ion Concentration; D015640:Ion Channel Gating; D007700:Kinetics; D009994:Osmolar Concentration; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism*; D012604:Scorpion Venoms / Q000378:metabolism* / Q000633:toxicity; D013601:T-Lymphocytes / Q000378:metabolism*
chemical_list: D015221:Potassium Channels; D012604:Scorpion Venoms; D018999:Charybdotoxin